Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.34 USD | +0.83% | -3.27% | -21.74% |
04-26 | Cytokinetics Appoints Sung Lee as CFO | MT |
04-26 | Cytokinetics, Incorporated Appoints Sung H. Lee as Executive Vice President, Effective as of May 8, 2024 | CI |
Business Summary
Number of employees: 423
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Muscle Activators
100.0
%
| 95 | 100.0 % | 8 | 100.0 % | -92.04% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 95 | 100.0 % | 8 | 100.0 % | -92.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Robert Blum
CEO | Chief Executive Officer | 60 | 30/06/98 |
Kari Loeser
CMP | Compliance Officer | - | 31/10/21 |
Stuart Kupfer
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/19 |
Daniel Casper
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Fady Malik
CTO | Chief Tech/Sci/R&D Officer | 59 | 31/12/97 |
Eric Terhaerdt
COO | Chief Operating Officer | - | 31/12/18 |
Diane Weiser
IRC | Investor Relations Contact | - | 31/03/15 |
John Faurescu
LAW | General Counsel | - | - |
Yulymae Dinapoli
HRO | Human Resources Officer | - | 31/10/21 |
Jeff Lotz
SAM | Sales & Marketing | - | 31/08/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy Wysenski
BRD | Director/Board Member | 66 | 19/11/20 |
Edward Kaye
BRD | Director/Board Member | 75 | 19/05/16 |
Santo Costa
BRD | Director/Board Member | 78 | 30/09/10 |
B. Parshall
BRD | Director/Board Member | 69 | 06/02/13 |
Wendell Wierenga
BRD | Director/Board Member | 76 | 08/02/11 |
Sandy Smith
BRD | Director/Board Member | 76 | 04/03/12 |
John Henderson
CHM | Chairman | 80 | 31/01/09 |
Robert Blum
CEO | Chief Executive Officer | 60 | 30/06/98 |
Director/Board Member | 63 | 07/04/22 | |
Muna Bhanji
BRD | Director/Board Member | 61 | 16/02/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 104,576,087 | 103,954,120 ( 99.41 %) | 0 | 99.41 % |
Company contact information
Cytokinetics, Inc.
350 Oyster Point Boulevard
94080, South San Francisco
+650 624 3000
http://www.cytokinetics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.74% | 6.85B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CYTK Stock
- Company Cytokinetics, Incorporated